Clinical Trials Directory

Trials / Completed

CompletedNCT07374822

Real-World Study of Helicobacter Pylori Eradication Success and Its Determinants

Study on the Real-World Eradication Success Rate of Helicobacter Pylori Infection and Its Influencing Factors

Status
Completed
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
Run-hua Li · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the real-world effectiveness of different treatment regimens used to eradicate Helicobacter pylori (H. pylori) infection in routine clinical practice. H. pylori is a common bacterial infection that can lead to chronic gastritis, peptic ulcers, and gastric cancer. Treatment success varies widely in real-world settings due to factors such as antibiotic resistance, patient characteristics, and treatment adherence. This retrospective observational study will review medical records of patients who underwent H. pylori testing and/or eradication treatment at Shenzhen Hospital of Southern Medical University between 2016 and 2023. No additional tests, visits, or interventions will be performed beyond standard clinical care. The study will collect information on demographics, comorbidities, treatment regimens, test results, and eradication outcomes. The primary goal is to determine the real-world eradication success rate of commonly used treatment regimens. A secondary goal is to identify factors that may influence treatment effectiveness. Findings from this study may help clinicians choose more effective treatment strategies and improve patient outcomes in everyday clinical practice.

Conditions

Interventions

TypeNameDescription
OTHERNo Study-Assigned InterventionParticipants receive standard-of-care H. pylori eradication regimens as determined by their treating physicians. The study does not assign or modify any treatment. Data are collected retrospectively from routine clinical records.

Timeline

Start date
2024-05-01
Primary completion
2025-05-31
Completion
2025-05-31
First posted
2026-01-29
Last updated
2026-01-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07374822. Inclusion in this directory is not an endorsement.